These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 27490937)
1. Predictions of the Pharmacokinetics in Burn Injury Patients using Regression Models - Case Study with Levofloxacin. Srinivas NR Drug Res (Stuttg); 2016 Oct; 66(10):555-560. PubMed ID: 27490937 [TBL] [Abstract][Full Text] [Related]
2. Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models. Srinivas NR; Syed M Drugs R D; 2016 Mar; 16(1):69-79. PubMed ID: 26747454 [TBL] [Abstract][Full Text] [Related]
3. Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application. Srinivas NR; Syed M J Pain Palliat Care Pharmacother; 2016; 30(1):13-24. PubMed ID: 26865407 [TBL] [Abstract][Full Text] [Related]
4. Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models. Bhamidipati RK; Syed M; Mullangi R; Srinivas N Xenobiotica; 2018 Feb; 48(2):148-156. PubMed ID: 28290233 [TBL] [Abstract][Full Text] [Related]
5. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis. Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961 [TBL] [Abstract][Full Text] [Related]
6. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Kiser TH; Hoody DW; Obritsch MD; Wegzyn CO; Bauling PC; Fish DN Antimicrob Agents Chemother; 2006 Jun; 50(6):1937-45. PubMed ID: 16723549 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of levofloxacin in healthy volunteers and in patients suffering from typhoid Fever. Usman M; Ashraf M; Khokhar MI; Ashiq B; Masood MI; Afzal S; Omer O; Ali M; Qadir MI Iran J Pharm Res; 2013; 12(1):147-54. PubMed ID: 24250583 [TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution. Gombar VK; Hall SD J Chem Inf Model; 2013 Apr; 53(4):948-57. PubMed ID: 23451981 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections. Kontou P; Manika K; Chatzika K; Papaioannou M; Sionidou M; Pitsiou G; Kioumis I Int J Antimicrob Agents; 2013 Sep; 42(3):262-7. PubMed ID: 23830621 [TBL] [Abstract][Full Text] [Related]
11. New pharmacokinetic methods: I. Estimation of mean serum concentration from trough serum concentration. Browne TR; Greenblatt DJ; Szabo GK; Evans JE; Evans BA J Clin Pharmacol; 1990 Jun; 30(6):482-8. PubMed ID: 2355100 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers. Park SI; Oh J; Jang K; Yoon J; Moon SJ; Park JS; Lee JH; Song J; Jang IJ; Yu KS; Chung JY Antimicrob Agents Chemother; 2015 Aug; 59(8):4429-35. PubMed ID: 25987620 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of levofloxacin in Korean patients. Kiem S; Ryu SM; Lee YM; Schentag JJ; Kim YW; Kim HK; Jang HJ; Joo YD; Jin K; Shin JG; Ghim JL J Chemother; 2016 Aug; 28(4):308-13. PubMed ID: 25976699 [TBL] [Abstract][Full Text] [Related]
14. Dual Incorporation of the in vitro Data (IC50) and in vivo (Cmax) Data for the Prediction of Area Under the Curve (AUC) for Statins using Regression Models Developed for Either Pravastatin or Simvastatin. Srinivas NR Drug Res (Stuttg); 2016 Aug; 66(8):402-6. PubMed ID: 27144659 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys. Aboubakr M; Uney K; Elmas M Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration]. Gu Q; Zhu ZH; Ge M; Ge WH Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476 [TBL] [Abstract][Full Text] [Related]
18. Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic Systems. Bouzas L; Hermida J; Tutor JC Clin Lab; 2004; 50(3-4):187-91. PubMed ID: 15074474 [TBL] [Abstract][Full Text] [Related]
19. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567 [TBL] [Abstract][Full Text] [Related]
20. A system of equations to approximate the pharmacokinetic parameters of lacosamide at steady state from one plasma sample. Cawello W; Schäfer C Epilepsy Res; 2014 Aug; 108(6):1068-75. PubMed ID: 24893832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]